Adalimumab Therapy Improves Intestinal Dysbiosis in Crohn’s Disease

The response to treatment with biologic drugs, in patients with Crohn’s disease, could be associated with changes in gut microbiota composition. The aim of our study was to analyse the modification of microbiota during adalimumab therapy in patients with Crohn’s disease. We perfo...

Full description

Bibliographic Details
Main Authors: Davide Giuseppe Ribaldone, Gian Paolo Caviglia, Amina Abdulle, Rinaldo Pellicano, Maria Chiara Ditto, Mario Morino, Enrico Fusaro, Giorgio Maria Saracco, Elisabetta Bugianesi, Marco Astegiano
Format: Article
Language:English
Published: MDPI AG 2019-10-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/8/10/1646

Similar Items